Figure 8 Investment Strategies LLC acquired a new position in shares of Danaher Co. (NYSE:DHR – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 9,156 shares of the conglomerate’s stock, valued at approximately $2,102,000. Danaher makes up about 2.1% of Figure 8 Investment Strategies LLC’s investment portfolio, making the stock its 19th biggest position.
Several other large investors also recently made changes to their positions in the company. Heck Capital Advisors LLC bought a new stake in Danaher during the 4th quarter valued at $27,000. Decker Retirement Planning Inc. acquired a new position in shares of Danaher during the fourth quarter valued at about $31,000. Golden State Wealth Management LLC bought a new stake in shares of Danaher during the fourth quarter worth about $31,000. Strategic Financial Concepts LLC acquired a new stake in shares of Danaher in the 4th quarter worth about $31,000. Finally, Pineridge Advisors LLC lifted its position in Danaher by 63.3% in the 4th quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock valued at $34,000 after acquiring an additional 57 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
A number of analysts have commented on the company. Stephens reissued an “overweight” rating and set a $315.00 price objective on shares of Danaher in a report on Wednesday, October 23rd. KeyCorp raised their price objective on Danaher from $290.00 to $310.00 and gave the company an “overweight” rating in a research note on Wednesday, October 23rd. Jefferies Financial Group reduced their target price on shares of Danaher from $285.00 to $260.00 and set a “buy” rating for the company in a research note on Wednesday, January 29th. StockNews.com lowered shares of Danaher from a “buy” rating to a “hold” rating in a research report on Saturday, December 14th. Finally, Wells Fargo & Company reduced their price objective on shares of Danaher from $280.00 to $240.00 and set an “equal weight” rating for the company in a research report on Thursday, January 30th. Seven equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $278.00.
Insider Transactions at Danaher
In related news, SVP Brian W. Ellis sold 5,700 shares of the company’s stock in a transaction that occurred on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the sale, the senior vice president now owns 20,230 shares of the company’s stock, valued at approximately $4,534,149.90. This represents a 21.98 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 11.10% of the company’s stock.
Danaher Stock Performance
NYSE DHR opened at $203.56 on Friday. The firm has a market cap of $147.03 billion, a P/E ratio of 38.55, a price-to-earnings-growth ratio of 2.68 and a beta of 0.83. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. The company’s 50 day moving average is $230.49 and its 200-day moving average is $250.28. Danaher Co. has a 12-month low of $196.80 and a 12-month high of $281.70.
Danaher (NYSE:DHR – Get Free Report) last posted its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, hitting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same quarter in the prior year, the company earned $2.09 EPS. Sell-side analysts predict that Danaher Co. will post 7.67 earnings per share for the current year.
Danaher Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Friday, January 31st. Stockholders of record on Friday, December 27th were given a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a dividend yield of 0.53%. The ex-dividend date was Friday, December 27th. Danaher’s dividend payout ratio is presently 20.45%.
Danaher Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Read More
- Five stocks we like better than Danaher
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Upstart’s Uptrend Is Just Getting Started: Its Time to Load Up
- Stock Market Sectors: What Are They and How Many Are There?
- Archer Aviation Lands BlackRock Investment—What’s Next for ACHR?
- Growth Stocks: What They Are, Examples and How to Invest
- Buffett Buys More Occidental Petroleum—Sticking to His Playbook
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.